Lindsay Wright was voted in at today’s Spark AGM, alongside two other new directors and the chair and CEO.
The takeover battle has seen the company’s value double since November.
The company admits the Novitas decision is a ‘significant blow’ but says it’s not a knockout.
The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
The dual-listed retailer says it’s yet to see any marked improvements in consumer confidence following recent cuts to interest rates.
The December quarter is traditionally the best for the casino business, but Star continued to go backwards.
The partnership has ridden the e-commerce boom in the US, with logistics centres in strategic locations.
Analysts are positive about equities in 2025, but their diverse views suggest investors need to do their homework rather than just follow the index.
WATCH: How NZ King Salmon is preparing for growth while navigating existing headwinds and government goals.
According to one analyst, 2025 just can’t be as bad as 2024.